Journal of Hepatology
Volume 56, Supplement 1 , Pages S13-S24, 2012

Management of critically-ill cirrhotic patients

  • Pere Ginès

      Affiliations

    • Liver Unit, IMDiM, Hospital Clinic Barcelona, University of Barcelona and IDIBAPS and Ciberehd, Barcelona, Spain
    • Centre hépato-biliaire; Hôpital Paul Brousse, Villejuif, France; Université Paris-Sud, UMR-S 785 and Unite INSERM 785, Villejuif, France
    • Corresponding Author InformationCorresponding author. Address: Liver Unit, Hospital Clýnic, Villarroel 170; ZC: 08036, Barcelona. Spain. Tel.: +34 93 2275400; fax: +34 93 4515522
  • ,
  • Javier Fernández

      Affiliations

    • Liver Unit, IMDiM, Hospital Clinic Barcelona, University of Barcelona and IDIBAPS and Ciberehd, Barcelona, Spain
    • Corresponding Author InformationJ. Fernández: Tel.: +34 93 2275400
  • ,
  • François Durand

      Affiliations

    • Instituto Reina Sofía de Investigación Nefrológica (IRSIN), Spain
    • Corresponding Author InformationF. Durand: Tel.: +33 1 40 875510
  • ,
  • Faouzi Saliba

      Affiliations

    • Hepatology and Liver Intensive Care, Hospital Beaujon, INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3. Hospital Beaujon, Clichy, France
    • Corresponding Author InformationF. Saliba: Tel.: +33 1 45 596412

Summary 

Cirrhotic patients are prone to develop life-threatening complications that require emergency care and ICU admission. They can present specific decompensations related to cirrhosis such as variceal bleeding and hepatorenal syndrome (HRS) or other critical events also observed in the general population such as severe sepsis or septic shock. Clinical management of all these entities requires a specific approach in cirrhosis. Cirrhotic patients have a hyperdynamic circulation with high cardiac output and low systemic vascular resistance in the absence of infection [1,2]. Circulatory dysfunction increases the susceptibility of critically-ill cirrhotic patients to develop multiple organ failure and attenuates vascular reactivity to vasopressor drugs [3]. HRS, a severe functional renal failure occurring in patients with advanced cirrhosis and ascites, is also secondary to this circulatory dysfunction that leads to an extreme renal vasoconstriction [2]. Moreover, hypotensive cirrhotic patients require a carefully balanced replacement of volemia, since overtransfusion increases portal hypertension and the risk of variceal bleeding and undertransfusion causes tissue hypoperfusion which increases the risk of multiple organ failure [4,5]. Cirrhotic patients are also at a high risk for development of other bleeding complications and are more susceptible to nosocomial infections [6,7]. This extreme complexity of critically-ill cirrhotic patients requires a specific medical approach that should be known by general intensivists since it has a negative impact on patient prognosis. This review will focus on the diagnostic approach and treatment strategies currently recommended in the critical care management of patients with cirrhosis.

Keywords:  Acute Variceal Bleeding , Hepatorenal syndrome (HRS) , Hepatic encephalopathy , Severe Sepsis , Septic Shock , Acute on Chronic Liver Failure , SOFA and MELD score

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8278(12)60003-8

doi:10.1016/S0168-8278(12)60003-8

Journal of Hepatology
Volume 56, Supplement 1 , Pages S13-S24, 2012